Jan 18, 2022 Sema4 has entered into an agreement to acquire GeneDx Inc in a $623,000,000 deal.

Sema4 based at Stamford, Connecticut, United States.
” Biotechnology, Health Care”

Acquirer’s Website: http://www.sema4.com

GeneDx Inc based at Gaithersburg, Maryland, United States. “GeneDx is a leader in clinical genomics and rare disease. Read about our unparalleled database, deep clinical knowledge and expertise in variant interpretation.”

Acquiree’s Website: http://www.genedx.com